Seller record · onyxresearch.shop

Onyx Research

Recorded September 2026 · Standard v1.1

Fails 4 of 8 criteria. S1, prescriber requirement: No clinician, physician or prescriber is named across the eleven pages read. The only gate on entry is a self-asserted age of twenty one. 3 more criteria also fail; see the table below.

Research vendor. Passes 4 of 8 criteria. Recorded against Standard v1.1.

A research peptide seller whose certificate library is the unusual part: a signed certificate per lot, tied to a lot number, and reachable without an account. It names no company anywhere on its own pages.

Operating entity About, contact, terms, privacy, the research-use agreement and the site-wide footer were read, and no legal entity name appears on any of them. The only name printed anywhere, including the copyright line, is the brand.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	FAIL	onyxresearch.shop
S2	Prescription gating	FAIL	onyxresearch.shop/product/tesamorelin-10mg/
S3	Pharmacy identification	FAIL	onyxresearch.shop/terms-conditions/
S4	Compounding disclosure	PASS	onyxresearch.shop/terms-conditions/
S5	Analytical documentation	PASS	onyxresearch.shop/test-results/
S6	Business address	FAIL	onyxresearch.shop/contact-us/
S7	Price disclosure	PASS	onyxresearch.shop/product/tesamorelin-10mg/
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1FAILNo clinician, physician or prescriber is named across the eleven pages read. The only gate on entry is a self-asserted age of twenty one.Source: onyxresearch.shop.

S2FAILA product page carries a quantity selector and an add-to-cart button with no step in between, and the cart loads directly. Nothing beyond the age click-through stands between a visitor and an order.Source: onyxresearch.shop/product/tesamorelin-10mg/.

S3FAILNo pharmacy is named, and the terms say the opposite in the seller's own words: it is not a compounding pharmacy under 503A and not an outsourcing facility under 503B.Source: onyxresearch.shop/terms-conditions/.

S4PASSThe seller offers no compounded drug and says so. A footer notice on every page read states that its products are not evaluated by the Food and Drug Administration and are for laboratory research use only.Source: onyxresearch.shop/terms-conditions/.

S5PASSThe test-results page lists a signed certificate per lot for every catalog item, each tied to a lot number. One certificate was fetched directly and returned a genuine document of 288 kilobytes rather than a page about certificates.Source: onyxresearch.shop/test-results/.

S6FAILNo street address appears on any of the eleven surfaces read. The contact page offers an email address and stated support hours and no postal address.Source: onyxresearch.shop/contact-us/.

S7PASSPrices are printed on the shop grid and on every product page, reachable with no account, among them a tesamorelin vial at 85.50 dollars against a struck-through 95 dollars.Source: onyxresearch.shop/product/tesamorelin-10mg/.

S8PASSNo letter names the storefront in the FDA index under three spellings, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: research peptides in vials, capsule research compounds.

Unpaid link. Onyx Research does not pay the site, and nothing is earned when it is used. Funding.

Visit Onyx Research

50 sellers pass S1, prescriber requirement · every record below dated August 2026

See all 50 on the S1 criterion page — 42 more than shown here.

This seller fails criteria a medical service must meet. The records above belong to sellers that pass S1; some are partner links, disclosed on their records.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.